175.90
Quest Diagnostics Inc (DGX) 最新ニュース
Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Quest Diagnostics (DGX) Sees Raised Target Price by JP Morgan | - GuruFocus
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Quest Diagnostics (DGX) Receives Price Target Increase from JPMo - GuruFocus
Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus - MSN
Quest Diagnostics Stock: A Leader But Waiting For Better Price (NYSE:DGX) - Seeking Alpha
Quest Settles Fired Black Phlebotomist's Retaliation Suit - Law360
Bullish on Quest Diagnosis Inc. - The Globe and Mail
This Company Extended Its Post-Earnings Rally to Record Highs - The Globe and Mail
Fitch elevates Quest Diagnostics’ rating to ’BBB+’ with stable outlook By Investing.com - Investing.com Canada
Fitch elevates Quest Diagnostics’ rating to ’BBB+’ with stable outlook - Investing.com
Piper Sandler Adjusts Price Target on Quest Diagnostics to $200 From $180, Maintains Neutral Rating - marketscreener.com
Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight - GuruFocus
Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years - Benzinga
Truist Financial Keeps Their Hold Rating on Quest Diagnostics (DGX) - The Globe and Mail
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings - Benzinga
Morgan Stanley Adjusts Quest Diagnostics Price Target to $182 From $172, Maintains Overweight Rating - marketscreener.com
Baird Adjusts Quest Diagnostics Price Target to $194 From $191, Maintains Outperform Rating - marketscreener.com
Jefferies Adjusts Quest Diagnostics Price Target to $195 From $190, Maintains Buy Rating - marketscreener.com
Quest Diagnostics (DGX) Sees Price Target Increase Following Str - GuruFocus
Mizuho Securities Adjusts Quest Diagnostics Price Target to $190 From $189 - marketscreener.com
Quest Diagnostics (DGX) Sees Price Target Increase Following Strong Q1 Results | DGX Stock News - GuruFocus
A Glimpse Into The Expert Outlook On Quest Diagnostics Through 12 Analysts - Benzinga
Quest Diagnostics Incorporated (NYSE:DGX) Q1 2025 Earnings Call Transcript - Insider Monkey
Truist Raises Price Target on Quest Diagnostics to $190 From $182, Keeps Hold Rating - marketscreener.com
Quest Diagnostics (DGX) Sees Price Target Boost from Barclays | - GuruFocus
Quest Diagnostics (DGX) Sees Price Target Boost from Barclays | DGX Stock News - GuruFocus
Quest Diagnostics (DGX) Stock Analysis: Unpacking the 5.32% Potential Upside for Investors - DirectorsTalk Interviews
Quest Diagnostics Inc (DGX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Quest Diagnostics earnings bolstered by March rebound, sending stock up 3% - MSN
Quest Diagnostics Inc (DGX) Q1 2025 Earnings Call Highlights: St - GuruFocus
Quest Diagnostics Inc (DGX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations - GuruFocus
Quest Diagnostics: Q1 Earnings Snapshot - CTPost
Barclays Raises Quest Diagnostics' Price Target to $185 From $175 - marketscreener.com
Evercore ISI Adjusts Quest Diagnostics Price Target to $180 From $175 - marketscreener.com
Quest Diagnostics Inc (DGX) Trading 6.97% Higher on Apr 22 - GuruFocus
Quest Diagnostics (DGX) Reports Strong Q1 2025 Revenue Growth - GuruFocus
Quest Diagnostics Shines With Strong Profits And Revenue Growth - Finimize
Leerink Adjusts Price Target on Quest Diagnostics to $189 From $184 - marketscreener.com
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook ConfidenceQuest Diagnostics (NYSE:DGX) - Benzinga
Quest Diagnostics (DGX) Increases EPS Outlook After Strong Q1 Performance - GuruFocus
Quest Diagnostics Q1 Earnings & Revenues Top Estimates, Stock Up - Nasdaq
Quest Diagnostics up 8% following earnings beats, EPS guidance raise - Seeking Alpha
Quest Diagnostics Posts Better-Than-Expected Earnings, Joins Pentair, 3M, Danaher And Other Big Stocks Moving Higher On TuesdayAkso Health (NASDAQ:AHG), Bitdeer Technologies (NASDAQ:BTDR) - Benzinga
Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025 - The Malaysian Reserve
Quest Diagnostics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Quest Diagnostics’ Q1 Earnings Align With Wall Street Estimates: Retail’s In Wait-And-Watch Mode - MSN
Quest Diagnostics (DGX) Q1 Earnings and Revenues Beat Estimates - Yahoo
Quest beats quarterly profit estimates on strong demand for diagnostic tests - marketscreener.com
Strong Q1 Revenue Performance by Quest Diagnostics (DGX) Exceeds Projections | DGX Stock News - GuruFocus
Quest Diagnostics Inc (DGX) Q1 2025 Earnings: EPS of $1.94 Beats Estimate, Revenue Hits $2.65 Billion - GuruFocus
Quest Diagnostics Q1 Adjusted Earnings, Revenue Increase; 2025 Adjusted Earnings Outlook Affirmed - marketscreener.com
Quest Diagnostics (DGX) Beats Q1 Estimates, Adjusts FY25 Guidance - GuruFocus
大文字化:
|
ボリューム (24 時間):